J0665 – Injection, bupivicaine, not otherwise specified, 0.5 mg

Long description

Injection, bupivicaine, not otherwise specified, 0.5 mg

Short description

Inj, bupivacaine, nos, 0.5mg

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

July 1, 2023

Last change

January 1, 2024 – No change

Nearby J codes

• J0641 – Injection, levoleucovorin, not otherwise specified, 0.5 mg
• J0642 – Injection, levoleucovorin (khapzory), 0.5 mg
• J0643 – Injection, leucovorin calcium, not otherwise specified, 1 mg
• J0644 – Injection, leucovorin calcium (avyxa), 1 mg
• J0650 – Injection, levothyroxine sodium, not otherwise specified, 10 mcg
• J0651 – Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
• J0652 – Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
• J0654 – Injection, liothyronine, 1 mcg
• J0666 – Injection, bupivacaine liposome, 1 mg
• J0668 – Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
• J0670 – Injection, mepivacaine hydrochloride, per 10 ml
• J0675 – Injection, carboprost tromethamine, 0.1 mg
• J0681 – Injection, ceftobiprole medocaril sodium, 3 mg
• J0687 – Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
• J0688 – Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg
• J0689 – Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg